RMS Evolution
ActiveSummary
RMS Evolution has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €142,771 and a net result of -€3,601. Equity has been stable since 2019 (±1.4% per year). Its solvency ranks better than 89% of 9,845 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 05-06-1997 Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460
- Establishment unit
- 2.082.150.827 1750 Lennik, since 10-06-1997
- Financial year end
- 30 June
- Peppol
- Reachable since 26-02-2026
Board and ownership
- Olivier WoutersManaging director
- Lutgarde Omer Cecilia VANDE GAERDirector · since 21-05-1997
- Willy Maurice Maria VANDERSMISSENDirector · since 01-10-2003
- Holdings
- Shares in 1 company RMS Medical Devices
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.1%
- Gross margin
- -€2,922
- ▼ 175%
- Loss
- €3,601
- ▲ 85.9%
- Equity
- €142,771
- ▼ 2.5%
- Total assets
- €164,586
- ▲ 0.2%
Score breakdownraises risk1 change of registered office in 24 monthsLiquidity: current ratio 0.62, cash €576lowers riskFounded in 1997Equity €142,771 (86.7% of total assets)Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 90% of them on solvency, 48% on liquidity, 27% on profitability and 35% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 33 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, abbreviated format
Annual accounts 2025 filed on 19-12-2025 PDF all 28 filings
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result for 2025 is a loss of €3,319, larger than the loss of €1,447 in 2024. It is the lowest result since 2021.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Wholesale trade (NACE 46). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | - | - | €348 | €348 | €384 | €397 | ▲ 3.3% |
| Gross operating margin9900 | -€754 | -€1,134 | -€1,362 | -€796 | -€2,323 | -€1,063 | -€2,922 | ▼ 175% |
| Operating profit (loss)9901 | -€1,172 | -€1,554 | -€1,783 | -€1,144 | -€2,671 | -€1,447 | -€3,319 | ▼ 129% |
| Financial income75/76B | - | - | - | €239 | €504 | €370 | €380 | ▲ 2.6% |
| Recurring financial income75 | - | - | - | €239 | €504 | €370 | €380 | ▲ 2.6% |
| Financial charges65/66B | - | - | - | €453 | €815 | €860 | €662 | ▼ 23.0% |
| Recurring financial charges65 | €90 | €120 | €131 | €453 | €815 | €860 | €662 | ▼ 23.0% |
| Profit (loss) for the period before taxes9903 | -€1,262 | -€1,674 | -€1,914 | -€1,357 | -€2,982 | -€1,938 | -€3,601 | ▼ 85.9% |
| Profit (loss) for the period9904 | -€1,262 | -€1,674 | -€1,914 | -€1,357 | -€2,982 | -€1,938 | -€3,601 | ▼ 85.9% |
| Profit (loss) for the period to be appropriated9905 | -€1,262 | -€1,674 | -€1,914 | -€1,357 | -€2,982 | -€1,938 | -€3,601 | ▼ 85.9% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €163,440 | €163,213 | €164,347 | €164,538 | €163,625 | €164,187 | €164,586 | ▲ 0.2% |
| Fixed assets21/28 | €151,147 | €151,147 | €151,147 | €151,147 | €151,147 | €151,147 | €151,147 | = |
| Financial fixed assets28 | €151,147 | €151,147 | €151,147 | €151,147 | €151,147 | €151,147 | €151,147 | = |
| Current assets29/58 | €12,293 | €12,067 | €13,201 | €13,391 | €12,478 | €13,040 | €13,439 | ▲ 3.1% |
| Amounts receivable within one year40/41 | €11,286 | €11,670 | €12,770 | €13,109 | €12,113 | €12,483 | €12,863 | ▲ 3.0% |
| Other amounts receivable41 | - | - | - | €13,109 | €12,113 | €12,483 | €12,863 | ▲ 3.0% |
| Current investments50/53 | - | - | - | €282 | - | - | - | - |
| Cash at bank and in hand54/58 | €660 | €50 | €431 | - | €365 | €557 | €576 | ▲ 3.4% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €163,440 | €163,213 | €164,347 | €164,538 | €163,625 | €164,187 | €164,586 | ▲ 0.2% |
| Equity10/15 | €156,237 | €154,563 | €152,649 | €151,292 | €148,310 | €146,372 | €142,771 | ▼ 2.5% |
| Contributions10/11 | €24,789 | - | - | €24,789 | €24,789 | €24,789 | €24,789 | = |
| Reserves13 | €131,448 | €129,774 | €127,860 | €127,860 | €127,860 | €127,860 | €127,860 | = |
| Non-distributable reserves130/1 | - | - | - | €2,479 | €2,479 | €2,479 | €0 | ▼ 100% |
| Reserves not available under the articles1311 | - | - | - | €2,479 | €2,479 | €2,479 | €0 | ▼ 100% |
| Distributable reserves133 | - | - | - | €125,381 | €125,381 | €125,381 | €127,860 | ▲ 2.0% |
| Profit (loss) carried forward14 | - | - | - | -€1,357 | -€4,339 | -€6,277 | -€9,878 | ▼ 57.4% |
| Amounts payable17/49 | €7,203 | €8,651 | €11,698 | €13,246 | €15,315 | €17,815 | €21,815 | ▲ 22.5% |
| Amounts payable within one year42/48 | €7,203 | €8,303 | €11,698 | €13,246 | €15,315 | €17,815 | €21,815 | ▲ 22.5% |
| Other amounts payable47/48 | - | - | - | €13,246 | €15,315 | €17,815 | €21,815 | ▲ 22.5% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€1,262 | -€1,674 | -€1,914 | -€1,357 | -€2,982 | -€1,938 | -€3,601 | ▼ 85.9% |
| Operating cash flow (approximation) | -€1,262 | -€1,674 | -€1,914 | -€1,357 | -€2,982 | -€1,938 | -€3,601 | ▼ 85.9% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | €0 | €0 | - |
| Change in cash | - | -€610 | €381 | - | - | €192 | €19 | ▼ 90.2% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 28 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 30-06-2025 | abbreviated format | 19-12-2025 | 2025-00587651 | |
| 30-06-2024 | abbreviated format | 03-12-2024 | 2024-00609226 | |
| 30-06-2023 | abbreviated format | 26-01-2024 | 2024-00007396 | |
| 30-06-2022 | abbreviated format | 26-01-2023 | 2023-00004337 | |
| 30-06-2021 | abbreviated format | 15-12-2021 | 2021-80600230 | |
| 30-06-2020 | abbreviated format | 30-12-2020 | 2020-77600460 | |
| 30-06-2019 | abbreviated format | 23-12-2019 | 2019-76700246 | |
| 30-06-2018 | abbreviated format | 13-12-2018 | 2018-74000506 | |
| 30-06-2017 | abbreviated format | 12-12-2017 | 2017-71500050 | |
| 30-06-2016 | abbreviated format | 05-01-2017 | 2017-00200248 |
Board & ownership
Directors
Board 3
Day-to-day management 1
Owners and capital
Capital transactions
- 22-05-2026 Capital stated in the deed · 100 shares
- 03-12-2024 Converted to unavailable equity
Mandate history
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| Lutgarde Omer Cecilia VANDE GAER |
|
| Willy Maurice Maria VANDERSMISSEN |
|
| Pieter-Jan Jongeling |
|
| Olivier Wouters |
|
| Lutgarde Vande Gaer |
|
| Willy Vandersmissen |
|
Network & group
Holdings and subsidiaries
1 holdingHoldings 1
- RMS Medical DevicessubsidiarySourceown accounts 30-06-2025Equity €5.7m Profit of €1.1m in 2025 (profit of €1.2m in 2024) Checked score 9099.87%
Companies at the same address
1 other companyConnections & network
3 current directorsThe network starts from the directors of RMS Evolution. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
22-05
Gazette deed
Resignations: Willy Vandersmissen (director) and Lutgarde Vande Gaer (director)Appointments: Pieter-Jan Jongeling (director) and Olivier Wouters (gedelegeerde tot het dagelijks bestuur) · Capital · Power of attorney11 points ▸
- General meeting, 2026-04
- Director resignation, Willy Vandersmissen (director)
- Director resignation, Lutgarde Vande Gaer (director)
- Director appointment, Pieter-Jan Jongeling (director)
- Board meeting, 01-04-2026
- Capital
- Other provision, “enige bestuurder, neerlegging en bekendmaking vereniging alle aandelen en identiteit aandeelhouder” (deed in Dutch)
- Director appointment, Olivier Wouters (gedelegeerde tot het dagelijks bestuur)
- Power of attorney, Olivier Wouters
- Registered-office move, Omer De Vidtslaan 50,B-1760 Roosdaal
- (...) holds all the shares
22-05
Gazette deed
Company renamed from RMS EQUIPMENT to RMS Evolution2 points ▸
- General meeting, 18-05-2026
- Name change, RMS Evolution
03-12
Gazette deed
Resignations: Willy Maurice Maria VANDERSMISSEN (manager) and Lutgarde Omer Cecilia VANDE GAER (manager)Reappointments: Willy Maurice Maria VANDERSMISSEN (director) and Lutgarde Omer Cecilia VANDE GAER (director) · Director discharge · Registered office clause12 points ▸
- Director resignation, Willy Maurice Maria VANDERSMISSEN (manager)
- Director resignation, Lutgarde Omer Cecilia VANDE GAER (manager)
- Director reappointment, Willy Maurice Maria VANDERSMISSEN (director (not named in the articles))
- Director reappointment, Lutgarde Omer Cecilia VANDE GAER (director (not named in the articles))
- Director discharge, Willy Maurice Maria VANDERSMISSEN
- Director discharge, Lutgarde Omer Cecilia VANDE GAER
- Registered office clause, “1750 Lennik,Olmenlaan 48, Zesde besluit” (deed in Dutch)
- Other provision, “stemming en sluiting, vergadering gesloten” (deed in Dutch)
- General meeting, 21-10-2024
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “vormen en meerderheden statutenwijziging, opheffen statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
Codes under NACEBEL 2003
2 activities
- De aan- en verkoop,de distributie in de ruimste zin van het woord,hierin begrepen de verkoop op commissie,de in-en uitvoer,de huur- en verhuur van alle artikelen,goederen,apparaten,machines,installaties,gebruiksvoorwerpen allerhande zonder enige uitzondering,die in de medische wereld voor medische doeleinden worden aangewend maar dan in de ruimste zin van het woord genomen.
- Alle handelingen,in de ruimste zin van het woord,die van aard zijn haar maatschappelijke bedrijvigheid te vergemakkelijken of uit te breiden,hetzij rechtstreeks,hetzij onrechtstreeks.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the addresses
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 23097D0275/00L000 | Flanders | 1,034 m² | 1 · 262 m² | 9.9 m · 3 |
| 23075B0259/00R013 | Flanders | 836 m² | 1 · 233 m² | 7.9 m · 2 |